JP2025511361A - 抗菌性の４，５ ジアリール－チオフェン－２－イル ヘキサフルオロプロパン－２－ｏｌｓ - Google Patents

抗菌性の４，５ ジアリール－チオフェン－２－イル ヘキサフルオロプロパン－２－ｏｌｓ Download PDF

Info

Publication number
JP2025511361A
JP2025511361A JP2024558968A JP2024558968A JP2025511361A JP 2025511361 A JP2025511361 A JP 2025511361A JP 2024558968 A JP2024558968 A JP 2024558968A JP 2024558968 A JP2024558968 A JP 2024558968A JP 2025511361 A JP2025511361 A JP 2025511361A
Authority
JP
Japan
Prior art keywords
bacterial infection
compound
compounds
pharma
antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024558968A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025511361A5 (https=
Inventor
ロス マクマスター，クリストファー
ジェームズ バーデン，クリストファー
Original Assignee
デノバメド インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by デノバメド インク． filed Critical デノバメド インク．
Publication of JP2025511361A publication Critical patent/JP2025511361A/ja
Publication of JP2025511361A5 publication Critical patent/JP2025511361A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/12—Radicals substituted by halogen atoms or nitro or nitroso radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2024558968A 2022-04-05 2023-04-05 抗菌性の４，５ ジアリール－チオフェン－２－イル ヘキサフルオロプロパン－２－ｏｌｓ Pending JP2025511361A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263327386P 2022-04-05 2022-04-05
US63/327,386 2022-04-05
PCT/CA2023/050462 WO2023193101A1 (en) 2022-04-05 2023-04-05 Antibacterial 4,5 diaryl-thiophen-2-yl hexafluoropropan-2-ols

Publications (2)

Publication Number Publication Date
JP2025511361A true JP2025511361A (ja) 2025-04-15
JP2025511361A5 JP2025511361A5 (https=) 2026-01-14

Family

ID=88243656

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024558968A Pending JP2025511361A (ja) 2022-04-05 2023-04-05 抗菌性の４，５ ジアリール－チオフェン－２－イル ヘキサフルオロプロパン－２－ｏｌｓ

Country Status (6)

Country Link
US (1) US20250161266A1 (https=)
EP (1) EP4504714A4 (https=)
JP (1) JP2025511361A (https=)
CN (1) CN118974031A (https=)
CA (1) CA3245167A1 (https=)
WO (1) WO2023193101A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4381311A (en) * 1980-12-29 1983-04-26 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-α-(polyhalomethyl)-2-thiophenemethanols
MXPA06001500A (es) * 2003-08-11 2006-05-15 Wyeth Corp Compuestos de 3-aril-4-hidroxifuranona y composiciones farmaceuticas y veterinarias que los contienen.
AU2012222832B2 (en) * 2011-03-03 2017-03-30 Denovamed Inc. Antimicrobial/adjuvant compounds and methods
WO2019169479A1 (en) * 2018-03-05 2019-09-12 Denovamed Inc. Diphenyl substituted thiophene-2-amide derivatives and pharmaceutical compositions thereof useful as antimicrobial

Also Published As

Publication number Publication date
US20250161266A1 (en) 2025-05-22
CA3245167A1 (en) 2023-10-12
CN118974031A (zh) 2024-11-15
EP4504714A1 (en) 2025-02-12
EP4504714A4 (en) 2026-03-25
WO2023193101A1 (en) 2023-10-12

Similar Documents

Publication Publication Date Title
JP5410748B2 (ja) 抗菌剤およびカルベオール、チモール、オイゲノール、ボルネオールならびにカルバクロールから選択される活性成分を含んでなる医薬組成物
US10603289B2 (en) Process for the manufacture of ajoene derivatives
US9012655B2 (en) Antimicrobial/adjuvant compounds and methods
CA2818100C (en) Compounds and their use
JP2014521739A (ja) 窒素含有化合物及びその使用
CA2383522A1 (en) Neurotherapeutic composition and method
JP6411482B2 (ja) 窒素含有化合物およびその使用
JP7309214B2 (ja) 抗菌性物質として有益なジフェニル置換チオフェン－２－アミド誘導体およびそれらの医薬組成物
CA2218916A1 (en) Dialkyltiacumicin compounds
WO2008140973A1 (en) Semi-synthetic glycopeptides with antibacterial activity
JP2025511361A (ja) 抗菌性の４，５ ジアリール－チオフェン－２－イル ヘキサフルオロプロパン－２－ｏｌｓ
KR102893477B1 (ko) 당뇨병성 족부 감염의 치료제
TWI413520B (zh) 用作抗細菌劑之喹啉衍生物
US20100130509A1 (en) Novel antibiotics
WO2019216933A1 (en) Antibiotic conjugates
WO2026015821A1 (en) Antibiotic alkaloid and methods of generating and use thereof
CN121181578A (zh) 一种噻唑喹啉酮类化合物及其应用
WO2017216764A1 (en) N-(alkanoyl)-7-oxo-6-sulfooxy-1,6-diazabicyclo[3.2.1]octane-2-carbonylhydrazide derivatives and their use as antibacterial agents

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260105

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260105